Title: 'Greener' Friedel-Crafts acylations: a metal- and halogen-free methodology.
Journal: Organic letters 20110506
Title: A randomized, controlled, dose-ranging study investigating single doses of GW406381, naproxen sodium, or placebo in patients with acute pain after third molar tooth extraction.
Journal: The Clinical journal of pain 20090901
Title: A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.
Journal: European journal of neurology 20080401
Title: Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.
Journal: Medscape journal of medicine 20080101
Title: GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury.
Journal: Pain 20070301
Title: The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.
Journal: The Journal of pharmacology and experimental therapeutics 20050301
Title: Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20041101
Title: Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation.
Journal: International journal of pharmaceutics 20021001
Title: Zhao FY, et al. GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury. Pain. 2007 Mar;128(1-2):78-87.
Title: Boswell DJ, et al. Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies. Medscape J Med. 2008;10(11):259.
